As shown in Figure 6, all cancer cell lines were statistically equally sensitive to treatment as MDA-MB-231, suggesting that the MC-based STAT3 decoy strategy could be applied not only to TNBC but also to other human tumor types. This evidence concerns the gene STAT3 and neoplasm.